Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10245 publications

Hypersensitivity reactions to biologics in chronic rheumatic diseases: prevalence and associated factors.

Hypersensitivity reactions to biologics in chronic rheumatic diseases: prevalence and associated factors.

Journal: Expert opinion on drug safety
Published: September 26, 2025

Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanercept.

Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanercept.

Journal: JAAD case reports
Published: September 25, 2025

Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM).

Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM).

Journal: Journal of the American Society for Mass Spectrometry
Published: September 18, 2025

TNF-alpha inhibitor therapy for granuloma annulare.

TNF-alpha inhibitor therapy for granuloma annulare.

Journal: The Journal of dermatological treatment
Published: September 17, 2025

Safety and Efficacy of Perispinal Etanercept for Chronic Stroke: A Randomized Clinical Trial.

Safety and Efficacy of Perispinal Etanercept for Chronic Stroke: A Randomized Clinical Trial.

Journal: Neurology
Published: September 04, 2025

Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events.

Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events.

Journal: JAMA dermatology
Published: September 03, 2025

Necrobiosis Lipoidica Diabeticorum: A Rare and Difficult-to-Treat Condition.

Necrobiosis Lipoidica Diabeticorum: A Rare and Difficult-to-Treat Condition.

Journal: Cureus
Published: August 12, 2025

Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.

Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.

Journal: BMJ case reports
Published: August 09, 2025

Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review.

Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review.

Journal: Clinical rheumatology
Published: August 08, 2025

How treatment choices influence the onset and outcomes of uveitis ın juvenile idiopathic arthritis: a retrospective cohort study.

How treatment choices influence the onset and outcomes of uveitis ın juvenile idiopathic arthritis: a retrospective cohort study.

Journal: Expert opinion on biological therapy
Published: August 07, 2025

The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis.

The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 07, 2025

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Journal: The Cochrane database of systematic reviews
Published: August 06, 2025
Showing 1-12 of 10,245

Last Updated: 10/31/2025